Ming‐Shen Dai

机构：Tri-Service General Hospital, National Defense Medical Center

发表论文 116 篇 · 总被引 1858 次 · h-index 20

代表论文

• Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer (2024 · Journal of Clinical Oncology · 被引 86)
• Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial (2024 · Nature Medicine · 被引 45)
• Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer (2023 · JAMA Oncology · 被引 28)
• Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis (2025 · Antimicrobial Agents and Chemotherapy · 被引 8)
• Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2− breast cancer (2024 · Journal of the Chinese Medical Association · 被引 8)
• The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis (2024 · Diagnostics · 被引 7)